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Abstract
Nanodiamonds have potential in biomedical uses, as they are non-toxic and exhibit non-
blinking fluorescence behavior when they are enriched with nitrogen vacancy centers. In
order for them to be useful in biomedical applications, they need to be functionalized. In
this experiment, a pIII library of M13 bacteriophage were panned versus 100 nm nanodia-
monds enriched with approximately 500 nitrogen vacancy centers to find phage that have
an affinity for these nanoparticles. The phage DNA was sequenced and found to have the
protein sequence SKMYHTP. At this point, although we have sequences of peptide that bind
to nanodiamond, we are unable to determine the affinity or best binders without additional
biopanning rounds and testing.
Thesis Supervisor: Angela Belcher
Title: W M. Keck Professor of Energy in Materials Science and Engineering and Biological
Engineering
3
4
Acknowledgments
I would like to thank Dr. Angela M. Belcher and Dr. Michael Rubner for introducing me to the
world of biomaterials, and Dr. Belcher's Biomolecular Materials Group for the opportunity
to work with them on this research. Many thanks to Mr. Matthew Klug for being my mentor
throughout this research project, providing valuable assistance, for his contributions to the
experimental protocols, and TEM imaging and fluorometer measurements of nanodiamonds.
I would like to thank Dr. Nimrod Heldman for his advice and suggestions on my experiments,
as well as reviewing this thesis. Thanks to Dr. Gaelen T. Hess, Mr. John Casey, and Dr. Jifa Qi
for their valuable input and training. Thanks to Ms. Gill Bilski for proofreading this thesis.
Thanks to Mr. Christohpe S. Gouardo, Mr. Jan Jaap van den Hurk, Mr. Peter M. Kijac, Ms.
Karen Straube, and Mrs. Ellien Laramee-Byers for their words of encouragement and keeping
me sane. Last but not least, thanks to my family for their support and understanding.
5
6
Contents
Contents 7
List of Figures 9
List of Tables 11
1 Introduction 13
1.1 Properties of Nanodiamonds . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.2 The M 13 Bacteriophage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.3 Biopanning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2 Methods and Materials 19
2.1 Biopanning round 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2 Biopanning round 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.3 Biopanning round 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.4 ELISA Binding Assay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.5 Q uantification .................................... . 28
2.5.1 Spectrophotometry ................................. 28
2.5.2 Titering . . . . . ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.6 DNA Sequencing .................................. . 30
2.7 Naming Conventions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.7.1 Biopanning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
7
2.7.2 DNA Sequencing ................................. 31
3 Results and Discussion 33
3.1 Biopanning ...................................... . 33
3.2 DNA Sequencing .................................. . 35
3.3 ELISA Binding Assay ...................................... 36
4 Conclusion 39
Bibliography 41
8
1
List of Figures
1-1 TEM of nanodiamonds with an average size of 100 nm ............. 14
1-2 Fluorometric plot of 100 nm nanodiamonds. .................... 15
1-3 Protein schematic of the M13 bacteriophage ................... 16
1-4 The biopanning process .................................... 17
2-1 ELISA Binding Assay . . . . . . . . . . . . . . . . . . . . . . . . . .. -. . . 28
3-1 Over saturated plate from round 2 . . . . . . . . . . . . . . . . . . . . . . . . . 34
3-2 Absorbance Measurements of HRP/Anti-M13 conjugated antibody ...... 38
9
10
Solutions required for biopanning procedure . . . . . . . . . . . . . . . .
Solutions required for ELISA binding assay procedure . . . . . . . . . .
Target Titer Dilutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Biopanning Series Legend . . . . . . . . . . . . . . . . . . . . . . . . . . .
Phage concentration between rounds (plaque counts) . . . . . . . . . . .
Post-amplification phage concentrations . . . . . . . . . . . . . . . . . . .
Amino acid sequences from all rounds . . . . . . . . . . . . . . . . . . . .
ELISA binding assay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11
List of Tables
2.1
2.2
2.3
2.4
3.1
3.2
3.3
3.4
. . . 21
. . . 25
. . . 29
. . . 31
. . . 33
. . . 35
. . . 36
. . . 37
12
Chapter 1
Introduction
There is increasing interest in nanodiamonds for their magnetic and optical properties,
which arise as a result of defects in their crystal structure. These properties have led to
their use as photo-stable fluorescent nanoparticles"] in biomarker applications, in quantum
computing applications,[2] and in imaging applications.l In addition, compared to other
metal nanoparticles such as gold and silver, they are less toxic, thus more biocompatible.[4 1
These properties make them an attractive material for use in biomaterial designs.
For nanodiamonds to be useful in a biomaterials "toolkit," ways to functionalize the surface
must be found. For example, there is published research on functionalizing nanodiamonds via
thiolation of the surface.[5,61 The goal for this work is to investigate whether certain variants
of a bacteriophage will exhibit high affinity for nanodiamond particles, and if so, find and
isolate the best candidates. To the best of our knowledge, this particular configuration has
not been investigated, and it is hoped that research in this area will eventually lead to the
conjugation of M13 bacteriophage to nanodiamonds as a new way of functionalizing the
particles. As there is existing research on functionalizing M13 bacteriophage 7 1 this research,
if successful, could lead to the phage, or just the peptide sequence, being utilized as a capping
agent for functionalizing the nanodiamond's surface.
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1.1 Properties of Nanodiamonds
Nanodiamonds' are manufactured by subjecting graphite to explosive shocks.[8] The average
particle size can be engineered to be anywhere from 4 nm to as large as 150 nm. As seen in
Figure 1-1, the resulting batches of particles are usually polydisperse with multiple facets and
irregular shape.
Figure 1-1: TEM of nanodiamonds with an average size of 100 nm. The scale bar is 100 nm in length.
Nanodiamonds do not possess intrinsic fluorescent properties. One way for them to
fluoresce is to bombard the particles with radiation, which results in the creation of nitrogen
vacancy (N-V) defect centers. Traditionally a high-energy (2 MeV) electron beam was used
for this purpose, but recently a less costly and more efficient2 method was discovered by
bombarding the the particles with medium-energy (40 KeV) He'.[91 Moreover, the fluores-
'also known as detonation diamonds
2According to Chang's paper, He' bombardment resulted in the creation of 40 vacancies per ion. A 2 MeV
electron created 0.1 vacancies.
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cence from nanodiamonds is superior to that of conventional fluorescent dyes in two ways:
nanodiamonds do not exhibit intermittent fluorescence ("blinking"), and are not subject to
photobleaching'.[ 9 In addition, the photons emitted from the nanodiamonds are capable of
penetrating human tissue. Those material properties, combined with cost-savings in their
production through the use of He* ionic bombardment, make them potential successors to
quantum dots.
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Figure 1-2: Fluorometric plot of 100 rn nanodiamonds. A 532 nmn laser was used to radiate the sample,
resulting in fluorescence at 660 nm.
1.2 The M13 Bacteriophage
The M13 bacteriophage (Figure 1-3) forms the basis of a biological toolkit that has seen many
uses as a template for designing nanostructures and materials, such as nanowires in battery
applications,1101 self-assembling single-walled carbon nanotubes,["I and stabilizing graphene
3Photobleaching is the loss of fluorescence after excitation with a light source, such as a laser.
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sheets.[El M13 bacteriophage can be genetically engineered to express a randomized library of
peptides that are expressed on the phage coat proteins, such as pVIII and pIII (Figure 1.2). M13
was chosen because researchers have successfully used it to bind to other carbon allotropes
such as carbon nanotubes1"] and graphene.112
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Figure 1-3: Protein schematic of the M13 bacteriophage.
We will focus on the pIII protein to form the basis for the variants. As seen in Figure 1-3,
five copies of the pIII protein are located at one end of the M13 bacteriophage. Each of the
pIII proteins have 405 amino acids, and are the largest proteins on the phage.[31 The amino
acid sequence is a function of gene III. A pIII library contains a diverse population of phage,
each with approximately 100 copies of a different amino acid sequence for pIII. This work is
based on the assumption that certain sequences in the library will exhibit high affinity to N-V
defects exposed on the nanodiamond's surface. To test this theory, we will use the panning
method to find and isolate the best candidates.
1.3 Biopanning
The panning process (Figure 1-4) entails mixing the phage library on a substrate coated with
the target nanodiamonds. After the substrate is exposed to the bacteriophage, a washing
buffer such as TBST (Tris buffered saline (TBS) with 0.1 % volume Tween-20) is used to wash
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Figure 1-4: The biopanning process.
away bacteriophage that were nonspecifically bound for the target. Two types of elutions were
done: an acid elution for the weak binding phage, and a bacterial elution for the strong binding
phage. An acid elution solution is used to wash away bacteriophage that have weak affinity
for the target. A solution containing bacteria cells is then introduced to the nanodiamonds
and the binders that survived the acid elution and presumably have the highest affinity for
the substrate can directly infect the viable E. coli cells. These cells are then harvested for
amplification of the binding sequences. The bacteriophage are reproduced in the amplification
stage, and the resulting bacteriophage are used for subsequent panning cycles. This process is
repeated 2-3 times to find the variant with the highest affinity. Throughout each cycle the
binding population is sampled and its DNA sequenced. Once final binding candidates have
been identified, their affinity for nanodiamonds is quantified via an ELISA binding assay.
17
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Chapter 2
Methods and Materials
The fluorescent nanodiamonds were obtained from Adamas Nanotechnologies. These Nan-
odiamonds had an average particle size of 100 nm and were enriched with approximately 500
nitrogen vacancy centers. The diamonds were acid treated by the vendor to produce COOH
groups on the surface to make the suspensions stable in aqueous solution.
The pIII library was purchased from New England Biolabs (Ph.D.-7 Phage Display Peptide
Library Kit, Catalog #E8100S), which included our phage display library and ER2738 E. coli
host strain. The experiment protocol for biopanning was modified from the instruction
manual14 1 that was packaged with the kit.
Three rounds of biopanning were conducted for each experiment, spanning 10 or more
days. Each round consisted of several major steps: biopanning, amplification, quantification,
and sequencing. At the end of the three rounds, the candidate phage was tested for binding
to the target and compared with wild type phage binding.
Every day, a culture of LB+Tet (5 mL of LB, 2.5 1iL of Tet) medium was inoculated with a
colony of E. Coli (ER2738 host strain) and incubated in a 37 0C shaker overnight. At least
one mid-log culture was made at the beginning of the following day by inoculating LB+Tet
(20 mL LB, 10 1.L Tet) with 200 iL of the overnight ER2738 culture in an autoclaved 250 mL
Erlenmeyer flask. The cultures were incubated in a 37 0C shaker for 2-2.5 hours.
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2.1 Biopanning round 1
To prepare for the biopanning procedure, 100 1 L of nanodiamond solution was placed in the
'Al" well of a 96-well round-bottomed polypropylene plate. The plate was placed in a 50 0C
oven overnight to evaporate the water. A number of solutions and IPTG-XGal/Tet plates
were also prepared (Table 2.1).
On the following day, a total of three mid-log' cultures were prepared for the amplification
of the eluted phage. This step was timed such that the cultures were ready immediately after
biopanning.
The well-plate with the immobilized nanodiamonds was removed from the oven, and
it was verified that the well was coated. BSA (Bovine Serum Albumin) blocking buffer was
added into the well until it was completely filled with a convex meniscus sitting on top thus
ensuing all well surface area was blocked. The blocking buffer's purpose was to minimize
non-specific binding of the phage to the plate material. The plate was incubated for one
hour at room temperature. While waiting for the incubation phase to complete, the pIII
phage library was diluted to a concentration of 2 x 1011 virions total (1 x 1011 pfu/mL) by
combining 20 1 L of stock phage with 180 1 L TBST (0.1 % Tween-20: This concentration of
TBST was used for the rest of round 1; 0.5% Tween-20 was used for rounds 2 and 3) in an
autoclaved microcentrifuge tube.
At the end of the incubation period, the buffer was poured off, and residual solution
removed by firmly slapping the plate face-down onto a clean paper towel, using a clean
section each time. The plate was rinsed six times with TBST, each time coating the well with
the solution then pouring it off and slapping the plate face-down onto a clean paper towel.
The wash was done quickly to avoid drying out of the well. 100 IL of the diluted phage was
added to the well and incubated on a plate shaker for 30 minutes at room temperature. While
waiting, agarose top was heated and 3 mL were aliquoted into 18 14 mL round bottom tubes.
The tubes were then kept warm in a 45 0C oven for use later. 18 IPTG-Xgal/Tet plates were
put into a 37 0C incubator for use later.
'Very important that they be mid-log because they are "ripe" for infection at this point
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Table 2.1: Solutions required for biopanning procedure. Solutions were stored at room temperature unless
otherwise specified.
Description
Millipore DI Water
LB Medium
TBS (Tris-buffered saline)
PBS (Phosphate Buffer Solu-
tion)
Magnesium Chloride Hexahy-
drate
PEG/NaCl solution
Agarose Top
Tet (Tetracycline)
BSA Blocking Buffer
TBST (0.1 % Tween-20)
TBST (0.5 % Tween-20)
Acid Elution Solution
Tris-HCl Buffer
IPTG-XGal/Tet
Autoclaved.
25 g of LB (Luria-Bertani) Broth in 1 L of DI water,
autoclaved.
Dilute 10 x TBS concentrate with DI Water, autoclaved.
MgCl 2-6H 2 0
200 g of PEG 8000 and 146 g of NaCl in 1 L of DI water,
autoclaved.
25g of LB, 7g of agarose and 1 g of MgCl 2-6H 20 in
1 L of DI water, autoclaved.
Dissolved 2 g of Tet powder in 50 mL of methanol. Cov-
ered with aluminum foil and stored at -20 0C.
5 mg/mL BSA (Bovine Serum Albumin protein) in 1x
TBS, stored at 4 0C.
0.1% Tween-20 in 1x TBS
0.5 % Tween-20 in 1x TBS
0.2 M Glycine-HCl, 1 mg/mL BSA (Bovine Serum Al-
bumin protein). Dissolved in 15 mL DI water, then
titrated with 1 M HCl until pH = 2.2.
1 M Trizma Hydrochloride. Titrated with 2 M NaOH
until pH = 9.1
For making IPTG-XGal/Tet plates. 32 g of LB Agar
in 1 L of DI water was autoclaved, then cooled down
to approximately 70 0C. 1 mL of IPTG, 1 mL of XGal
(1000x), and 0.5 mL of Tet (2000x) were added to the
cooled-down solution. Aliquoted 13 mL immediately
into petri dishes.
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Solution
At the end of the 30 minutes, non-binding phage in the well were discarded by pouring
off the solution and slapping the plate face-down on a clean paper towel. The well was then
rinsed with TBST 10 times, with the same procedure as before, taking care to use a clean
paper towel for each slap to avoid cross-contamination.
100 tL of acid elution buffer was added to the well to elute any weak binding phage. The
plate was shaken gently for 10 minutes at room temperature. The solution was pipetted into
an autoclaved microcentrifuge tube and neutralized with 15 tL of Tris-HCl buffer. 10 LL of
the solution was pipetted into another microcentrifuge tube for titering later. The rest of the
solution was added to one of the mid-log culture flasks and incubated in a 37 0C shaker for
4.5 hours2.
The plate was rinsed with TBST 10 times to remove any remaining weakly bound phage,
using the same procedure as before. 100 1 L of mid-log culture was added into the well to
allow strong binding phage to infect the bacteria cells. The culture was incubated on a plate
shaker for two minutes. The infected cells were pipetted into an autoclaved microcentrifuge
tube, and 10 [tL of the cells were pipetted into another microcentrifuge tube for titering later.
The rest of the solution was added to another one of the mid-log culture flasks and incubated
in a 37 C shaker for 4.5 hours. At this point the two eluates were quantified with titering at
dilutions of 10x, 100x, 1000x, and 10,000x with an original volume of 2 [tL. See §2.5.2 for
procedures.
There are now two phage solutions being amplified for 4.5 hours: one that is acid eluted,
and one that is bacteria eluted. After amplification, 10 iL of each solution was pipetted into
autoclaved centrifuge tubes for titering'. The fluid in each flask was transferred to centrifuge
tubes and centrifuged for 20 minutes at 10,000 rpm at 4 0C to separate the much smaller virus
from the larger bacteria cells. The supernatant from each tube was transferred to fresh tubes
and 10 1 L of each solution was pipetted into autoclaved centrifuge tubes for titering '. 3.33 tL
2It was important that the cultures were not allowed to continue to amplify beyond 4.5 hours, since fast
growing phage may dominate the culture and cause the experiment to fail.
'See §2.5.2. Titered plates were labelled "Post-amplified, pre-PEG/NaCl, pre-centrifuge"-this titering was
optional, but done to assist in troubleshooting
4Titered plates were labelled "Post-amplified, pre-PEG/NaCl"-this titering was also optional but was done
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of PEG/NaCi was added to each tube. 10 1 L of each solution was pipetted into autoclaved
centrifuge tubes for titering'. They were placed in a 4 0C refrigerator to allow the phage to
precipitate overnight. The addition of PEG/NaCl causes the water molecules to be absorbed
by the polymer and be less available to solubilise the phage. This causes the bacteriophage
to precipitate. At this point all the solutions that were saved for titering were quantified
according to instructions in §2.5.1 and §2.5.2.
Taking great care not to disturb the solutions, they were transferred to the centrifuge and
centrifuged for 40 minutes at 14,000 rpm at 4 0C. After centrifugation we checked for a faint
white pellet at the bottom of the tube. If none was observed, more PEG/NaCI was added to
the tubes, placed in the 4 0C refrigerator overnight, and centrifuged the next day.
After discarding the supernatants, each of the pellets was resuspended in 1 mL of 1x
TBS, then transferred to autoclaved microcentrifuge tubes. The tubes were centrifuged for
1 minute at 10,000 rpm to remove residual impurities. 0.2 mL of PEG/NaCl solution was
added to each tube and then the tubes were put into a tightly-packed ice bucket for at least
3 hours. Afterwards, the tubes were centrifuged for 30 minutes at 14,000 rpm to precipitate
the phage a second time. The supernatants were discarded, and the white phage pellet in
each tube was dissolved in 200 iL of 1x TBS. This was centrifuged for another minute at
10,000 rpm to remove any residual impurities. The supernatants were transferred to fresh
autoclaved microcentrifuge tubes and labelled as the amplified-purified eluates. 10 1 L of
each was pipetted into fresh microcentrifuge tubes and quantified according to instructions
in §2.5.1 and 2.5.2.
The two sets of titered plates were removed on the following day and counted. This
allows us to calculate accurately the concentration of the phage solutions. LB+Tet (3 mL of
LB, 1.5 ptL of Tet) was inoculated with 30 pL of the ER2738 overnight culture in 16 15 mL
round-bottomed tubes6. For each set of plates, 8 random plaques were removed from the
plate using a 1 mL pipette and transferred to the tubes. These will be amplified for DNA
to assist in troubleshooting
'Titered plates were labelled "Post-amplified, post-PEG/NaCl"
68 tubes for each elution
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sequencing. The tubes were incubated in the shaker at 37 0C for 4.5 hours. After amplification,
they were centrifuged for 30 minutes at 3300 rpm. The supernatants, which contain the phage
solution grown from each plaque, were transferred to new tubes, labelled using the naming
convention covered in §2.7.2, and stored in the 4 0C refrigerator. The supernatants were saved
for use later in the ELISA binding assay (See §2.4) . The pellet cells were resuspended in
250 1L of P1 buffer and transferred to autoclaved microcentrifuge tubes. They were prepared
for DNA sequencing using the QIAGEN Miniprep Kit (See §2.6).
To prepare for round 2, the same nanodiamonds were immobilized on a 24-well flat-
bottomed polystyrene well-plate', taking great care to place the 100 [tL drop at the center
of the well. A polystyrene plate was used for round 2 to cull the phage that had specificity
for polypropylene. The plate was put in the 50 0C oven overnight to evaporate the water. A
quick inventory was also conducted to make sure there were enough IPTG-XGal/Tet plates,
autoclaved Erlenmeyer flasks, autoclaved microcentrifuge tubes, clean centrifuge tubes, and
solutions on hand to continue with a second round of biopanning.
2.2 Biopanning round 2
The amplified-purified phage eluates from round 1 were diluted to 2 x 1012virions/mL to
be consistent with the concentration used in round 1. The polystyrene plate was removed
from the oven and checked for coverage. It was blocked and washed similar to round 1, but
substituting the 0.1 % Tween-20 TBST with the 0.5 % Tween-20 TBST for the washes. This
provides a more stringent test for binding than used in round 1.
600 1 L of the diluted amplified phage that were eluated with acid from round 1 biopan-
ning was added to the well. It was left to incubate on a plate shaker for 30 minutes at room
temperature. The solution was poured off the well, and the plate rinsed with TBST 10 times.
600 1iL of acid elution buffer was added to the well. The plate was shaken gently for 10 minutes
7We attempted to use 96-well polystyrene well-plates multiple times, but each time the nanodiamonds failed
to immobilize and fell out of the well when the BSA blocking buffer was poured off, forcing us to backtrack the
steps by a day
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at room temperature. The buffer was pipetted out into an autoclaved centrifuge tube, and the
plate rinsed with TBST 10 times. The steps in this paragraph were repeated for the diluted
bacterial eluate, substituting the acid elution buffer with mid-log cell cultures.
10 1iL of each of the eluted solutions was pipetted into fresh autoclaved centrifuge tubes
for quantification by titering. The rest were amplified for 4.5 hours, and the steps from round 1
post-amplification are identical for round 2.
2.3 Biopanning round 3
Steps for round 3 were similar to round 2, except the eluted solutions were not amplified
for purification as this was the final round. The plate used was a 96-well polypropylene
round-bottomed plate, the same type as the one in round 1. Plaques from titering this round's
pre-amplified eluted solutions were amplified for DNA sequencing.
2.4 ELISA Binding Assay
The solutions in Table 2.2 were required for the ELISA binding assay, which tests for binding
of our candidate phage vs. the target, compared to wild type phage.
Table 2.2: Solutions required for ELISA binding assay procedure. Solutions were stored at room tempera-
ture unless otherwise specified.
Solution Description
BSA Blocking Buffer At least 15 mL. 5 mg/mL BSA (Bovine Serum Albumin
protein) in 1 x TBS, stored at 4 0C.
TBST (0.5 % Tween-20) At least 400 mL. 0.5% Tween-20 in 1x TBS
Diluted HRP/Anti-M13 Mono- Diluted according to manufacturer's instructions.
clonal Conjugate
Substrate Solution Thermo Scientific 1-Step Turbo TMB-ELISA.
An overnight culture of ER2738 was made, using the same procedure as one made for
the biopanning rounds. In fresh autoclaved microcentrifuge tubes, 200 1iL of the target nan-
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odiamonds were diluted in 1100 iL of DI water. The top row (wells 1-6) of a fresh 96-well
polypropylene round-bottomed well plate was coated with the diluted nanodiamond solution
from one of the tubes. The same was repeated for the second row with the second tube. The
plate was placed in a 50 0C oven overnight to evaporate the water.
The following day, two solutions of 40 mL of LB, 0.4 mL of the overnight culture, 20 FtL of
Tet, and 0.04 g of MgCl 2 -6H 20 were mixed in autoclaved 250 mL Erlenmeyer flasks. 1 mL
of the candidate supernatant/phage solution put aside from biopanning for miniprep (see
pg. 24) was added to one flask, and 1 mL of wild type phage solution was added to the other.
Both were incubated in a shaker for 5-6 hours at 225-50 rpm at 37 0C. After amplification,
each solution was divided into two clean centrifuge tubes. The four centrifuge tubes were
centrifuged for 20 minutes at 10,000 rpm to separate the phage from the bacteria cells in the
solution. The supernatants were decanted into fresh centrifuge tubes, and 3 mL of PEG/NaCl
was added to each tube. Each tube was balanced by mass, and placed in a 4 0C refrigerator to
precipitate overnight.
The tubes were centrifuged for 45 minutes at 14,000 rpm at 4 0C. A compact white pellet
at the bottom of each tube was observed, indicating that phage had indeed precipitated from
the solution. The supernatant was discarded and the phage pellet dissolved with 1 mL of PBS
without vortexing. The solutions were transferred to fresh autoclaved microcentrifuge tubes
and centrifuged for 1 minute at 10,000 rpm to remove residual impurities. The supernatants
were transferred to new microcentrifuge tubes. To each tube we added 0.2 mL of PEG/NaCl,
and then put the tubes in a tightly-packed ice bucket for 3 hours.
After 3 hours, the tubes were centrifuged for 30 minutes at 14,000 rpm to precipitate
the phage for a second time. The supernatant was discarded and the white phage pellets
were dissolved in 200 1 L of PBS. The tubes were centrifuged for 1 minute at 10,000 rpm to
remove residual impurities. The supernatants were then transferred to new tubes. Each pair
of solutions was recombined for a total of 400 1 L per phage type. Each phage solution was
quantified with a spectrophotometer to obtain the final phage concentration.
The plate was removed from the 50 0C oven. Wells 1-6 in rows A-D were each blocked
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with 400 1iL of BSA blocking buffer. The same was done to wells on a separate plate ("dilution
plate") of the same type. Both plates were incubated for 2 hours at 4 0C. After incubation,
both plates were rinsed with TBST 6 times, slapping the plate face-down onto a clean section
of paper towel each time.
The candidate and wild type phage were both diluted to 1 x 1011 virions/mL. In the
dilution plate, 270 pL of BSA blocking buffer was dispensed into each of the wells in rows
A-D, column 2-6. Serial dilutions of the candidate phage was carried out by pipetting out
300 L from the 1 x 1013 virions/mL candidate phage solution and dispensing it into the first
well (Al). After pipetting the solution up and down to mix it, 30 iL of solution was pipetted
out of the first well and dispensed into the second well (A2). This was repeated until well A6.
The same dilution of the candidate phage was carried out in wells B1-B6, and of the wild type
phage in wells C1-C6 and Dl-D6. The aim was to obtain dilutions from 1 x 10' virions/mL
in the first column (1) to 1 x 108 virions/mL in the sixth column (6), with candidate phage in
rows A and B, and wild type phage in rows C and D.
100 1iL from each row of diluted phage from the dilution plate was transferred to the
target plate, such that rows A (coated) and C (uncoated) on the target plate were filled with
candidate phage, and rows B (coated) and D (uncoated) on the target plate were filled with
wild type phage. The target plate was placed in the 4 0C refrigerator overnight.
The plate was then rinsed 10 times with TBST, slapping the plate face-down onto a clean
section of paper towel each time. The HRP conjugate was diluted according to the manufac-
turer's instructions'. 200 1 L of diluted conjugate was added two each well and incubated at
room temperature for one hour on a plate shaker.
The plate was again rinsed 10 times with TBST, slapping the plate face-down onto a clean
section of paper towel each time. 150 pL of the substrate was added to each well using a multi-
pipette. The plate was incubated for 10 minutes with gentle agitation. The HRP conjugated
antibody will bind to the pVIII protein of phage immobilized on the nanodiamonds through
pIII binding. Upon exposure of HRP to the turbo max substrate, a colormetric reaction
8 GE Healthcare, HRP/Anti-M13 Monoclonal Conjugate, #27-9721-01)
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occurs, changing the color of the solution in the well (see Figure 2-1). The amount of phage
remaining in the well is proportional to the absorption peak of the by-product of the HRP
and the substrate at 652 nm. A Tecan infinite M200 Pro plate reader was used to analyze the
absorption peak.
Figure 2-1: ELISA Binding Assay. Anti-M13 anti-bodies conjugated with HRP are attached to the pVIII
protein coating of the bound phage. The ABTS substrate turns blue when it comes in contact
with HRP
2.5 Quantification
In our experiment, quantification primarily involved calculating phage concentration from
absorbance values from spectrophotometry and plaque counts from titering plates. Quantifi-
cation was often used to trace errors in experimental procedures, by comparing the pre- and
post-amplification concentrations.
2.5.1 Spectrophotometry
A NanoDrop ND-1000 UV-Vis Spectrophotometer was used to measure the absorbance
values of the phage solution at 269 nm and 320 nm. The instrument was initialized with 2 ptL
of Millipore DI water, then blanked with 2 VL of 1x TBS solution. For each phage solution,
2 [tL was placed on the pedestal, and the absorbance values recorded.
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The phage concentration was calculated using the formula in Equation 2.1.
[M13] = A269- A320 x 6 x 1017 [virions/mL] (2.1)7225
2.5.2 Titering
A titer was used to find the lowest concentration (highest dilution) at which infected bacterial
cells in an agarose top solution will grow on IPTG-XGal/Tet plates. A serial dilution was
made of the phage to obtain the four target dilutions (Table 2.3). 200 [iL of the mid-log culture
was dispensed into four autoclaved tubes, and 10 1iL of each dilution was transferred into
the tubes with the bacteria cells and then vortexed quickly. The contents of the tube were
dispensed into 14 mL tubes containing pre-heated agarose top. They were then transferred
to individual IPTG-XGal/Tet plates, cooled for five minutes, then placed upside down in
the incubator at 37 C to incubate overnight. In this process the virus solution infects E. coli
cells, which are then immobilized as the agarose cools into a matrix in the petri dish. The
phage grow by being amplified by the E. coli cell and the virus diffuses outward to infect
neighboring immobilized cells. These form spots of infected cells called plaques. The lacZ
gene engineered into the phage causes the plaques to turn blue when IPTG-XGal is present
in the plates.
Table 2.3: Target Titer Dilutions
Orig. Vol. Titer Dilution Factors
(pL) 1 2 3 4
Pre-Amp. 2 1 x 10 1 x 102 1 x 103 1 x 104
Post-Amp. 10 1 x 108 1 x 109 1 x 1010 1 x 1011
Blue plaques were counted for each of the plates the following day. Plates that were over
saturated with blue plaques were skipped. The phage concentration in plaque forming units
(pfu) per mL was calculated using the formula in Equation 2.2.
29
[M13] - (# plaques) (dilution factor)
original volume
2.6 DNA Sequencing
The following procedure was based on the "Plasmid DNA Purification Using the QIAprep
Spin Miniprep Kit and a Microcentrifuge" protocol from QIAGEN's Miniprep Handbook,[51
and required a QIAGEN Miniprep kit to proceed. The procedure assumes that the bacterial
cell pellets were already resuspended in 250 1L buffer P1 and transferred to microcentrifuge
tubes. To each tube 250 pL buffer P2 was added and mixed thoroughly by inverting the tube
4-6 times. The addition of buffer P2 lysed the cells in the solution. 350 pL of buffer N3 was
added to the microcentrifuge tubes and mixed immediately and thoroughly by inverting the
tube 4-6 times. The solutions were centrifuged for 10 minute at 13,000 rpm. The supernatants
were transferred to QlAprep spin columns by decanting. The spin columns were centrifuged
for 1 minute, and the flow-throughs were discarded. The spin columns were then washed
by adding 0.5 mL buffer PB, centrifuged for 1 minute, and the flow-throughs discarded. The
spin columns were further washed with 0.75 mL buffer PE and centrifuged for 1 minute. The
flow-throughs were discarded, and the spin columns were centrifuged for 1 minute to remove
residual buffers. The columns were then placed in fresh autoclaved microcentrifuge tubes.
EB buffer was heated up to 70 0C in the microwave oven, and 30 pL of the heated buffer EB
was added to each of the spin columns. After a minute, the columns were centrifuged for an
additional minute.
The spin columns were discarded, and the remaining solutions of DNA in the microcen-
trifuge tubes were saved. The DNA concentration was measured for each solution using the
NanoDrop ND-1000 UV-Vis Spectrophotometer. 8.8 pL of each solution was pipetted out
into PCR tubes. To each, 3.2 VL of primer (96 gIII sequencing primer) was added. The PCR
tubes were sent to the Koch Institute Biopolymers and Proteomics Facility for sequencing.
The result sequences, in the form of .abl files, were read by a script written in PERL,
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reverse complemented, and translated. The script searched for a string in the protein sequence
matching the pattern "YSHS.......GGG" where the "." represents the peptide of interest.
2.7 Naming Conventions
Due to the large amount of products from each round, the following naming convention was
adopted for labeling plates and solutions.
2.7.1 Biopanning
Each series of rounds were grouped into alphabet letters:
Table 2.4: Biopanning series legend
Series Panning target
A Adaimas Nanotechnologies, 100 nm nanodiamonds w/N-V Centers
B Adamas Nanotechnologies, 150 nm nanodiamonds w/H3 (N-V-N) Centers
Eluates were labelled "AE" for acid elution, and "BE" for bacterial elution. A sample label
for the bacterial elution from round 3 of panning against 100 nm nanodiamonds with N-V
centers would read "A3-BE."
2.7.2 DNA Sequencing
There were multiple attempts at sequencing DNA from each round. These attempts were
labeled "Batch 1," "Batch 2", etc. "A3B2-BE4" would designate something from series A,
Round 3, Batch 2 (DNA sequencing attempt 2), bacterial elution, plaque ID 49.
9Recall that 8 plaques were selected for DNA sequencing, thus plaque IDs have a value between 1 and 8
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Chapter 3
Results and Discussion
3.1 Biopanning
Phage concentrations from the biopanning experiment are reported in Tables 3.1 and 3.2. In
round 1, an increase of 5-6 orders of magnitude in phage concentration was observed, as evi-
dence that amplification succeeded. Spectrophotometry measurements of the post-amplified
eluate showed an increase of 5 orders of magnitude in phage concentration, confirming the
analysis from the plaque counts. The presence of phage in both pre- and post-amplification
stages suggests that there is the possibility that there are phage that may have affinity for the
nanodiamonds. It is possible that some of the eluted phage have affinity for the polypropylene
instead of the nanodiamond. However, blocking the well with BSA and TBST was intended
to prevent nonspecific binding.
Table 3.1: Phage concentration between rounds, as calculated from plaque counts. All values are in
pfu/mL.
Amp. Round 1 Round 2 Round 3
Stage AE BE AE BE AE BE
Pre 1.7 x 107 1.6 x 107 - - 4.5 x 104 8.5 x 104
Post 9.0 x 1012 1.2 x 1013 - - - -
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Figure 3-1: An over saturated plate from round 2. Infected colonies with DNA from phage library are the
dark spots in this figure.
In round 2, there were plaques observed in both pre- and post-amplification plates.
However there were problems with quantification. The plaques on pre-amplification plates-
while numerous-were very faint in color, and were extremely small (to roughly fractions of
a millimeter). An estimate of the number of plaques suggests that there were over 100 plaques
per plate, too numerous to yield an accurate calculation. The post-amplification plates were
also over saturated (defined as having > 100 plaques per plate. See Figure 3-1), thus no counts
were performed. A visual inspection of the pre-amplification and post-amplification plates
confirmed that the amplification worked, and thus plaques were selected from these plates
for amplification for DNA sequencing. The phage clones represented on the plates may be
possible candidates with affinity for the nanodiamonds. As a polystyrene well-plate was used
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Table 3.2: Post-ampfi cation phage concentration between rounds, as calculated from absorbance values
from a spectrophotometer. All values are in virions/mL. There were no phage counts for Round
3 as no amplhfication was required.
Round AE BE
1 6.6 x 1012 8.9 x 1012
2 4.5 x 1012 3.0 x 1012
for this round, an assumption was made that the change in material eliminated the phage
with affinity for polypropylene from round 1.
In the last round, no amplification was involved, so there were only plates for the pre-
amplification stage. The continued presence of phage suggests that there may be phage with
affinity for nanodiamonds. The use of a polypropylene well-plate for this round should have
eliminated any phage with affinity for polystyrene. Phage from this round were used for the
ELISA binding assay to test for affinity to nanodiamonds (see §3.3).
3.2 DNA Sequencing
The amino acid sequences for plaque samples from all three rounds are reported in Table 3.3.
We obtained diversity in the first round after four attempts at DNA sequencing. The earlier
attempts had failed due to an error in the amount of tetracycline used, causing all our cells to
die during the amplification phase for DNA sequencing. Even though only batch 2 of the
second and third rounds were reported, all attempts showed the same sequence: SKMYHTP.
That the same amino acid sequence dominated both latter rounds could be due to one
of three possibilities. Firstly, it was possible that there was external contamination in our
samples during preparations for DNA sequencing. That's highly unlikely because the DNA
sequencing showed that it came from the phage library-i.e. our results matched the pattern
peptide sequence YSHS ...... GGG in our known library. Secondly, there could have been
a "fast-grower" that overtook the slower growing phage sequences in culture during the
amplification phase for biopanning. Thirdly, it was also possible that it is the phage with
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affinity for nanodiamonds. It seemed unlikely this was the case because the sequence had taken
over the diversity at the second round, but we could not rule out this possibility. fHowever,
to truly rule out this last possibility, an ELISA binding assay would be required (See §3.3).
Based on other researchers' past experiences in the lab, the most probable situation is that
the SKMYHTP is a very fast growing virus sequence.
In future experiments, the amplification stage during biopanning will be shortened to
rule out the possibility of "fast-growers' with the goal of obtaining diverse DNA sequences
across all samples in each round.
Table 3.3: Amino acid sequences from all rounds. For Round 3 Batch 2, only the bacteria eluted samples
were sequenced, due to a lack of plaques from the acid eluted plates
Round 1 (A1B4)
NHAQHNS
LSSYHLT
NA - Low Signal
EVPRTMP
GTVWHNR
LLVRPDT
KSTPVYT
QHSDSTL
ELLPYKR
VSAFPLY
ETSVSPW
NVYYWRD
GSHEFPY
YPVYSKP
WKFPTFT
FGTNDSR
Round 2 (A2B2)
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
Round 3 (A3B2)
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
SKMYHTP
3.3 ELISA Binding Assay
Data from the ELISA binding assay is reported in Table 3.4, with our candidate phage from
phage solution A3B2-B1. The low absorbance values (< 0.1) show that there was not much
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-:1
Sample
AE1
AE2
AE3
AE4
AE5
AE6
AE7
AE8
BE1
BE2
BE3
BE4
BE5
BE6
BE7
BE8
phage for the conjugated anti-M13 monoclonal antibody to attach to, which made it too low to
be of use to draw any useful conclusions without further investigation. The plot in Figure 3-2
reflected the absorbance values after subtracting the background (uncoated) readings from
the coated readings. Unfortunately, due to time constraints, only one ELISA binding assay was
conducted prior to the submission of this work. If given enough time a second assay would be
conducted to investigate the absorbance data between the 1 x 1011 and 1 x 1013virions/mL
concentrations, where the candidate phage may exhibit higher affinity than the wild type
phage.
Table 3.4: ELISA binding assay. The absorbance wavelength was set at 652 nm.
Phage Concentration Coated Uncoated
(virions/mL) A3B2-B1 Wild type A3B2-B1 Wild type
1 x 108 0.0475 0.0505 0.0480 0.0458
1 x 109 0.0492 0.0522 0.0530 0.0487
1 x 1010 0.0508 0.0545 0.0472 0.0472
1 x 1011 0.0637 0.0653 0.0459 0.0475
1 x 1012 0.0901 0.0724 0.0501 0.0534
1 x 1013 0.0937 0.0960 0.0481 0.0475
For that second assay, 1-Step Ultra TMB-ELISA (Thermo Scientific) would substitute
for the 1-Step Turbo TMB-ELISA solution that was used in this work. The "Ultra" vari-
ant should provide a stronger signal. In addition, instead of a tenfold serial dilution from
1 x 1013 to 1 x 108 virions/mL, we would use a a fourfold or threefold serial dilution from
1 x 1013 virions/mL to increase the data resolution in the region of interest. Lastly, instead of
using one row per phage per coated and uncoated environment, we will use three rows per
phage per environment. The readings would be averaged in order to obtain a clearer reading.
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Figure 3-2: Absorbance Measurements of HRP/Anti-M13 conjugated antibody over a serial dilution of
candidate and wild type phage.
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Chapter 4
Conclusion
The biopanning rounds showed that there may be phage that have high-affinity for nanodi-
amonds enriched with nitrogen vacancies. The DNA sequencing results showed that we
obtained a diverse mix of phage in round 1, but a singular sequence in rounds 2 and 3. The
singular sequence may indicate either a phage that has high-affinity for the nanodiamonds,
or that the phages were overcome with a "fast-grower." Thus, additional experiments and
rounds are needed to rule out that latter possibility.
The ELISA assay reflected absorbance values that were too low. The adjusted plot showed
that there may be some promise for phage concentrations from 1 x 1013 to 1 x 1011 virions/mL.
Additional investigations are required to obtain a stronger signal and better data resolution, to
determine whether the candidate phage with the amino acid sequence SKMYHTP does indeed
have a affinity for nanodiamonds.
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